The total return over the past 12 months is -6.49% vs. +16.94% for the S&P 500. So far it's up -36.20% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (6.49%) | +217.80% | +6.76% | N/A | N/A | N/A |
| Total Return CAGR | (6.49%) | +217.80% | +6.76% | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Bright Minds Biosciences Inc. (DRUG)
| Year | Start price | End price | DRUG Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $78.04 | $49.79 | (36.20%) | +14.51% | (50.71%) |
| 2025 | $36.02 | $78.04 | +116.66% | +17.72% | +98.94% |
| 2024 | $1.43 | $36.02 | +2418.88% | +24.89% | +2393.99% |
| 2023 | $3.70 | $1.43 | (61.35%) | +26.19% | (87.54%) |
| 2022 | $15.85 | $3.70 | (76.66%) | (18.17%) | (58.49%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
